
|Articles|February 1, 2004
Design features make foldable IOL good pseudophakic option
Kansas City, KS-The foldable acrylic AR-40E IOL (Sensar with OptiEdge, AMO) contin-ues to provide positive results as the number of eyes with implants and duration of follow-up increase, said John D. Hunkeler, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
2
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
3
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5















































.png)


